The Biofarma Group site in Gallarate has special expertise in the development, production and packaging of nutraceuticals in solid forms, medical devices for oral use and sports nutrition products. The plant boats a strong expertise in the design and production of multi-layer tablets and advance coating solutions for healthcare industry.
The Gallarate site manufactures solid forms, packaged in blisters and bottles, and offers quality services such as: analytical and microbiological testing, stability studies, development and testing of packaging components, galenical and analytical development.
Gallarate facility delivers rapid and flexible solutions for the development and production of different major solid dosage forms. With a focus on innovation and quality, the plant specializes in a wide variety of galenic formulations, expertly tailored to meet the diverse needs of our customers:
multi-layer tablets;
ODT (orally disintegrating tablets);
chewable tablets;
microencapsulation.
Multi-layer tablet is an innovative technology for the oral administration of advanced formulations, incorporating active ingredients or mixtures of active substances with controlled and sustained release in a single product. Thanks to this technology, the product's action is optimised over time, ensuring a more targeted and effective action in the body. A guarantee in health care, for long-lasting, high-performance results.
The advantages:
prevention of incompatibility between active ingredients and excipients, which are kept separate from each other until the time of administration;
administration of the same or different substances, with controlled release and with a direct and diversified action in the target area;
the use of separate layers and different colours differentiates the product from other tablets and provides visual evidence of the use of different groups of ingredients (e.g. vitamins and minerals).
Encapsulation can be defined as a technology involving the inclusion of sensitive bioactive ingredients within one or more protective polymeric matrices. Biofarma Group's Gallarate plant is able to adopt this innovative technology to coat and protect an ingredient while maintaining its stability and efficacy and improving any undesirable characteristics.
The main benefits of microencapsulation:
controlled release in the body and during processing;
flavor and odor masking;
protection of nutrients for increased stability;
possibility of creating tailor-made associations.
Liquid food supplements
Medical devices
Probiotics
-1739355408.svg){kind=icon}
